Biggest News Aggregation in the World
📰 Intersect Ent News

Intersect Ent News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Intersect Ent. Real-time updates on events, politics, business and more.

Intersect ENT (NASDAQ:XENT) Coverage Initiated at StockNews.com

Analysts at StockNews.com assumed coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a research report issued to clients and investors on Wednesday. The brokerage set a “sell” rating on the medical equipment provider’s stock. Intersect ENT Price Performance XENT stock opened at $28.24 on Wednesday. The firm has a market cap of […]
United States Intersect Ent Inc Gabelli Funds Verition Fund Management America Corp Get Rating

Intersect ENT (NASDAQ:XENT) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a note issued to investors on Friday. The firm set a “sell” rating on the medical equipment provider’s stock. Intersect ENT stock opened at $28.24 on Friday. The stock has a 50-day moving average of $28.03 and a two-hundred day moving average […]
United States Morgan Stanley Intersect Ent Inc Omni Event Management Ltd Millennium Management Get Rating

Financial Contrast: LMF Acquisition Opportunities (NASDAQ:LMAO) versus Intersect ENT (NASDAQ:XENT)

Intersect ENT (NASDAQ:XENT – Get Rating) and LMF Acquisition Opportunities (NASDAQ:LMAO – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings. Profitability This table compares Intersect ENT and LMF […]
United States Menlo Park Company Profile Get Rating Intersect Ent Inc Acquisition Opportunities Company Profile Get Rating Acquisition Opportunities Inc

Intersect ENT (NASDAQ:XENT) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a note issued to investors on Thursday. The brokerage set a “sell” rating on the medical equipment provider’s stock. Shares of NASDAQ:XENT opened at $28.24 on Thursday. The firm’s 50 day moving average is $27.99 and its two-hundred day moving average is […]
United States Morgan Stanley Intersect Ent Inc Goldman Sachs Group Inc Invesco Ltd Company Profile Get Rating

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Intersect ENT, Inc. (NASDAQ:XENT) Short Interest Up 41.4% in April

Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,870,000 shares, a growth of 41.4% from the March 31st total of 2,030,000 shares. Currently, 8.7% of the shares of the company are short […]
United States Intersect Ent Inc Goldman Sachs Group Inc Norges Bank Blackrock Inc Sg Americas Securities

Calamos Advisors LLC Invests $5.53 Million in Intersect ENT, Inc. (NASDAQ:XENT)

Calamos Advisors LLC purchased a new position in Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 202,386 shares of the medical equipment provider’s stock, valued at approximately $5,527,000. Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Two […]
United States Morgan Stanley Intersect Ent Inc Calamos Advisors Swiss National Bank Company Profile Get Rating

StockNews.com Initiates Coverage on Intersect ENT (NASDAQ:XENT)

StockNews.com assumed coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a report issued on Thursday. The brokerage issued a hold rating on the medical equipment provider’s stock. Shares of Intersect ENT stock opened at $27.75 on Thursday. The stock has a 50 day moving average of $27.46 and a 200 day moving […]
United States Zurcher Kantonalbank Zurich Cantonalbank Company Profile Get Rating Intersect Ent Inc Wolverine Asset Management Lumature Wealth Partners

Brokerages Set Intersect ENT, Inc. (NASDAQ:XENT) Target Price at $25.95

Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) has been given a consensus recommendation of “Hold” by the six brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. The average 12-month price objective among brokers […]
Intersect Ent Inc Goldman Sachs Group Inc Norges Bank Blackrock Inc Company Profile Get Rating Walleye Capital

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science